Skip to content

Similar papers

Open access Jul 2026

Single‐cell atlas of neuroglial dynamics in SNCA‐A53T Parkinson's disease mouse model

This data indicates that suppression of dopaminergic neurons in the substantia nigra results in striatal dopamine depletion and motor dysfunction in Parkinson's disease, and further studies are needed to establish a specific mechanism behind this phenomenon.

B. Qin, Zichu Fu, Xuanxuan Zou et al. · 0 citations
Open access Jul 2026

Exploring ageing as a potential new therapeutic target for schizophrenia.

Increased age-related biological changes have been causally linked to various pathologies in the brain, including Alzheimer's and Parkinson's diseases. There is also evidence that schizophrenia could be included in this group of brain disorders that may actually be manifestations of a broader multisystemic premature ag...

Júlia Rius-Bonet, Julia Gras-Font, S. Macip · 0 citations
Review Open access Apr 2026

Genetic and environmental risk factors of Parkinsonism

Parkinsonian disorders comprise a broad spectrum of neurodegenerative diseases with a wide variety of pathogenetic processes. These processes lead to the formation of pathological proteins, resulting in the brain diseases called synucleinopathies, tauopathies or TDP-43 proteinopathies. There is currently growing suppor...

Petr Kanovsky, K. Menšíková, Pavel Čupr et al. · 0 citations
Jul 2026

Timing the Alzheimer's disease pathological cascade.

This scientific commentary refers to ‘Modelling the temporal evolution of plasma p-tau217, amyloid PET, tau PET and cognition’ by Cogswell et al. (https://doi.org/10.1093/brain/awag075).

W. Pelkmans, Vasiliki Bikou, Gemma Salvadó · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.